Pharmacological actions of the main metabolites of dihydroergotamine-Reference-Cited by-同舟云学术

Pharmacological actions of the main metabolites of dihydroergotamine

Published:1984 Issue:6 Volume:26 Page:699-705
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

M�ller-Schweinitzer E.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF00541928.pdf

Reference29 articles.

1. Aellig WH (1974) Venoconstrictor effect of dihydroergotamine in superficial hand veins. Eur J Clin Pharmacol 7: 137?139

2. Aellig WH (1976) Influence of ergot compounds on compliance of superficial hand veins in man. Postgrad Med J (Suppl) 52: 21?23

3. Aellig WH (1981) A new technique for recording compliance of human hand veins. Br J clin Pharmacol 11: 237?243

4. Aellig WH, Berde B (1969) Studies of the effect of natural and synthetic polypeptide type ergot compounds on a peripheral vascular bed. Br J Pharmacol 36: 561?570

5. Aellig WH, Nüesch E (1977) Comparative pharmacokinetic investigations with tritium-labeled ergot alkaloids after oral and intravenous administration in man. Int J Clin Pharmacol 15: 106?112

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Pharmacokinetics of Drugs Delivered to the Upper Nasal Space;Pharmaceutical Medicine;2023-08-03

2. Phytochemical profiling of Clerodendrum paniculatum leaf extracts: GC-MS, LC-MS analysis and comparative evaluation of antimicrobial, antioxidant & cytotoxic effects;Natural Product Research;2022-10-29

3. The role of α1- and α2-adrenoceptor subtypes in the vasopressor responses induced by dihydroergotamine in ritanserin-pretreated pithed rats;The Journal of Headache and Pain;2017-10-11

4. In Vitro Metabolism Evaluation of the Ergot Alkaloid Dihydroergotamine: Application of Microsomal and Biomimetic Oxidative Model;Planta Medica;2016-08-02

5. Inhaled drug therapy development for the treatment of migraine;Expert Opinion on Pharmacotherapy;2016-07-28